课题基金 / 基金详情

MODELING THE STRUCTURE OF A RECEPTOR WITH TWO ASSOCIATING TRANSMEMBRANE DOMAINS

MODELING THE STRUCTURE OF A RECEPTOR WITH TWO ASSOCIATING TRANSMEMBRANE DOMAINS
对具有两个相关跨膜域的受体结构进行建模
批准号:
7957685
负责人:
DAVID BAKER
金额:
$3.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2010-08-31

项目摘要

项目成果

DAVID BAKER的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Structures of intact receptors with single-pass transmembrane domains are essential to understand how extracellular and cytoplasmic domains regulate association and signaling through transmembrane domains. A chemical and computational method to determine structures of the membrane regions of such receptors on the cell surface is developed here and validated with glycophorin A. An integrin heterodimer structure reveals association over most of the lengths of the alpha and beta transmembrane domains and shows that the principles governing association of hetero and homo transmembrane dimers differ. A turn at the Gly of the juxtamembrane GFFKR motif caps the alpha TM helix and brings the two Phe of GFFKR into the alpha/beta interface. A juxtamembrane Lys residue in beta also has an important role in the interface. The structure shows how transmembrane association/dissociation regulates integrin signaling. A joint ectodomain and membrane structure shows that substantial flexibility between the extracellular and TM domains is compatible with TM signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
  • 批准号:
    10296596
  • 项目类别:
  • 资助金额:
    $72.36万
  • 财政年份:
    2021
  • 负责人:
    DAVID BAKER
  • 依托单位:
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
  • 批准号:
    10460648
  • 项目类别:
  • 资助金额:
    $71.39万
  • 财政年份:
    2021
  • 负责人:
    DAVID BAKER
  • 依托单位:
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
  • 批准号:
    10672446
  • 项目类别:
  • 资助金额:
    $70.38万
  • 财政年份:
    2021
  • 负责人:
    DAVID BAKER
  • 依托单位:
Project 4: Novel reagent development to enable molecular characterization
  • 批准号:
    10359195
  • 项目类别:
  • 资助金额:
    $44.88万
  • 财政年份:
    2020
  • 负责人:
    DAVID BAKER
  • 依托单位:
海外基金